Commodore Capital LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $1.18 Billion distributed in 36 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Merus N.V. with a value of $167M, Vera Therapeutics, Inc. with a value of $109M, Xenon Pharmaceuticals Inc. with a value of $106M, Vaxcyte, Inc. with a value of $105M, and Nuvalent, Inc. with a value of $96.2M.
Examining the 13F form we can see an increase of $62M in the current position value, from $1.12B to 1.18B.
Commodore Capital LP is based out at New York, NY
Below you can find more details about Commodore Capital LP portfolio as well as his latest detailed transactions.
